Amphastar Pharmaceuticals (AMPH) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $4.03.
- Amphastar Pharmaceuticals' Times Interest Earned fell 5269.23% to $4.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.93, marking a year-over-year decrease of 759.63%. This contributed to the annual value of $6.77 for FY2024, which is 666.55% down from last year.
- Latest data reveals that Amphastar Pharmaceuticals reported Times Interest Earned of $4.03 as of Q3 2025, which was down 5269.23% from $6.72 recorded in Q2 2025.
- In the past 5 years, Amphastar Pharmaceuticals' Times Interest Earned ranged from a high of $144.36 in Q4 2021 and a low of $4.03 during Q3 2025
- In the last 5 years, Amphastar Pharmaceuticals' Times Interest Earned had a median value of $10.24 in 2023 and averaged $42.04.
- As far as peak fluctuations go, Amphastar Pharmaceuticals' Times Interest Earned surged by 34124.45% in 2021, and later crashed by 9336.28% in 2024.
- Amphastar Pharmaceuticals' Times Interest Earned (Quarter) stood at $144.36 in 2021, then crashed by 50.37% to $71.65 in 2022, then plummeted by 92.03% to $5.71 in 2023, then rose by 23.08% to $7.03 in 2024, then crashed by 42.65% to $4.03 in 2025.
- Its Times Interest Earned was $4.03 in Q3 2025, compared to $6.72 in Q2 2025 and $5.93 in Q1 2025.